Dabitra 150 Capsule

Dabitra 150 Capsule is a prescription anticoagulant that contains dabigatran etexilate 150 mg in each capsule. It belongs to the direct thrombin inhibitor class and is used to help prevent and treat harmful blood clots. Dabitra 150 Capsule may be prescribed to reduce the risk of stroke in certain people with atrial fibrillation and to treat or prevent deep vein thrombosis and pulmonary embolism in appropriate patients. Because it is a full-strength capsule, it should only be used when a clinician has decided that this specific dose is appropriate.

How it works: After you swallow Dabitra 150 Capsule, the dabigatran etexilate is absorbed and converted in the body to active dabigatran. It then blocks thrombin, a key protein your blood uses to form clots, which helps keep clots from getting bigger and helps prevent new clots from forming.

Dabitra 150 Capsule is the higher-strength option compared with Dabitra 110 Capsule, so it is not the usual lower-dose starting choice for every patient. A doctor may choose Dabitra 150 Capsule when stronger anticoagulation is needed and when the patient’s kidney function, bleeding risk, age, and other medicines have been reviewed.

• Reducing stroke risk in non-valvular atrial fibrillation
• Treating deep vein thrombosis (DVT)
• Treating pulmonary embolism (PE)
• Preventing DVT or PE from coming back after treatment

• Swallow Dabitra 150 Capsule whole with a full glass of water; do not open, crush, or chew the capsule.
• Take it exactly as prescribed, usually at the same times each day.
• This capsule is not a chewable, and it should not be sprinkled on food.
• Food does not usually change how Dabitra 150 Capsule works, but taking it consistently helps.
• If you miss a dose, take it as soon as you remember unless it is almost time for the next dose; do not double up unless your prescriber tells you to.
• Do not stop Dabitra 150 Capsule on your own, because stopping suddenly can raise clotting risk.

Each Dabitra 150 Capsule provides dabigatran etexilate 150 mg. Depending on the reason it is prescribed, it may be taken once or twice daily, but the exact schedule and total daily amount are decided by the doctor. Do not exceed the prescribed dose; the maximum daily amount is based on your condition, kidney function, and bleeding risk, not on self-adjustment.

Do not change your dose or stop the medicine without speaking to your doctor.

Common side effects of Dabigatran Etexilate may include:

• Bruising more easily
• Bleeding from gums or nose
• Stomach pain or indigestion
• Nausea
• Upset stomach or diarrhea
• Heartburn-like symptoms

• Dabitra 150 Capsule is a higher-strength anticoagulant and can increase bleeding risk if the dose is not right for you.
• Tell your prescriber if you have kidney disease, because this medicine is cleared by the kidneys.
• Use extra caution if you are elderly, underweight, or have a history of bleeding, ulcers, or falls.
• Avoid taking other blood thinners, aspirin, or NSAIDs unless your clinician approves them.
• Limit alcohol, which can raise the chance of stomach irritation and bleeding.
• Tell every healthcare professional that you take Dabitra 150 Capsule before any surgery, dental work, or spinal procedure.
• Seek prompt help after any head injury, even if you feel fine at first.

• Other anticoagulants such as warfarin, apixaban, rivaroxaban, heparin, or enoxaparin
• Aspirin and other antiplatelet medicines such as clopidogrel
• NSAIDs such as ibuprofen or naproxen
• P-gp inhibitors or inducers, including amiodarone, dronedarone, verapamil, rifampin, and ketoconazole
• Certain herbal products that may affect bleeding, such as ginkgo or high-dose fish oil

Store Dabitra 150 Capsule in its original strip/box at room temperature, protected from moisture, and keep the capsules tightly sealed until use.